KELSEA DUNCAN: Open Payments
NPI 1306482294 · HOPKINSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 79 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $216 |
| Phathom Pharmaceuticals, Inc. | 31 | $213 |
| Janssen Biotech, Inc. | 15 | $210 |
| Ardelyx, Inc. | 10 | $201 |
| PFIZER INC. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $16 |
| QOL Medical, LLC | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: VOQUEZNA, TREMFYA, IBSRELA, RINVOQ, MAVYRET, SKYRIZI, VELSIPITY, ENTYVIO.
Industry payments across KY — which companies pay providers there.
